Viva Biotech Holdings (HKSE:01873) Price-to-Tangible-Book : 1.09 (As of Jun. 06, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Price-to-Tangible-Book?

As of today (2024-06-06), Viva Biotech Holdings's share price is HK$0.62. Viva Biotech Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$0.57. Hence, Viva Biotech Holdings's Price to Tangible Book Ratio of today is 1.09.

The historical rank and industry rank for Viva Biotech Holdings's Price-to-Tangible-Book or its related term are showing as below:

HKSE:01873' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.09 Med: 3.6 Max: 10.26
Current: 1.09

During the past 8 years, Viva Biotech Holdings's highest Price to Tangible Book Ratio was 10.26. The lowest was 1.09. And the median was 3.60.

HKSE:01873's Price-to-Tangible-Book is ranked better than
83% of 1218 companies
in the Biotechnology industry
Industry Median: 2.825 vs HKSE:01873: 1.09

A closely related ratio is called PB Ratio. As of today, Viva Biotech Holdings's share price is HK$0.62. Viva Biotech Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$1.88. Hence, Viva Biotech Holdings's P/B Ratio of today is 0.33.

Viva Biotech Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Viva Biotech Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Price-to-Tangible-Book Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.60

10.26

6.02

3.09

1.85

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial									6.02	3.50	3.09	2.54	1.85

Competitive Comparison of Viva Biotech Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Viva Biotech Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viva Biotech Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's Price-to-Tangible-Book falls into.

Viva Biotech Holdings Price-to-Tangible-Book Calculation

Viva Biotech Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.62	/	0.567
	=	1.09

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Viva Biotech Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings (HKSE:01873) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (HKSE:01873) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

VBIZF:USA VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation ("CDMO") and commercialisation services segment includes contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations.

Executives

Mao Chen Cheney	2101 Beneficial owner
Wu John Jiong	2201 Interest of corporation controlled by you
Fenghe Harvest Ltd	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Mao Jun	2501 Other
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
Zhou Min	2202 Interest of your spouse
Intertrust (singapore) Ltd.	2301 Trustee
Z&m International Holdings Limited	2201 Interest of corporation controlled by you
Zhang And Sons Limited	2101 Beneficial owner

Viva Biotech Holdings (HKSE:01873) Headlines

No Headlines